Is the Patient Infected with SARS-CoV-2?
- 19 March 2021
- journal article
- editorial
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 59 (4)
- https://doi.org/10.1128/jcm.00147-21
Abstract
The U.S. Food and Drug Administration currently uses the nasopharyngeal swab specimen as the reference standard for evaluation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) assays. We propose that the patient-infected status algorithm is a superior way to classify whether an individual is infected or not infected.Keywords
This publication has 9 references indexed in Scilit:
- Self-Collected Oral Fluid and Nasal Swabs Demonstrate Comparable Sensitivity to Clinician Collected Nasopharyngeal Swabs for Coronavirus Disease 2019 DetectionClinical Infectious Diseases, 2021
- The Sensitivity and Costs of Testing for SARS-CoV-2 Infection With Saliva Versus Nasopharyngeal SwabsAnnals of Internal Medicine, 2021
- At what times during infection is SARS-CoV-2 detectable and no longer detectable using RT-PCR-based tests? A systematic review of individual participant dataBMC Medicine, 2020
- Saliva or Nasopharyngeal Swab Specimens for Detection of SARS-CoV-2The New England Journal of Medicine, 2020
- Natural history of COVID-19 and current knowledge on treatment therapeutic optionsBiomedicine & Pharmacotherapy, 2020
- Simultaneous Evaluation of Diagnostic Assays for Pharyngeal and Rectal Neisseria gonorrhoeae and Chlamydia trachomatis Using a Master ProtocolClinical Infectious Diseases, 2019
- Evaluation of the performance of nucleic acid amplification tests (NAATs) in detection of chlamydia and gonorrhoea infection in vaginal specimens relative to patient infection status: a systematic reviewBMJ Open, 2019
- Discrepant analysis: how can we test a test?2000
- Discrepant Analysis: How Can We Test a Test?Journal of Clinical Microbiology, 2000